Fortis Malar Hospitals Ltd (FORTISMLR) — shareholding pattern, promoter holding, financials and share price

About Fortis Malar Hospitals Ltd (FORTISMLR)

Fortis Malar Hospitals Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as FORTISMLR and on the BSE under scrip code 523696. Its ISIN is INE842B01015.

Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital. [1]

Fortis Malar Hospital Limited operates as a multi-specialty hospital, providing healthcare services in various specialized departments including cardiology, neurosurgery, and gastroenterology.

In 2008, Fortis Healthcare Limited acquired Fortis Malar, changing the management and control of the company.

Listed peers in Hospital: Abate As Industries Ltd, Maitreya Medicare Ltd, Shanmuga Hospital Ltd, Sangani Hospitals Ltd, Aatmaj Healthcare Ltd, Soni Medicare Ltd.

Valuation & Returns

10 Jul 2026

At ₹51.79 a share on 10 Jul 2026, Fortis Malar Hospitals Ltd (FORTISMLR) was valued at a price-to-earnings ratio of 23.5x against an industry P/E of 61.73x and a price-to-book of 2.83x on a book value of ₹18.33 per share as of Mar 2026. Solomo computes return on equity of 12.02% and return on capital employed of 13.74% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
23.5x
Industry P/E
61.73x
P/B
2.83x
EPS (TTM)
₹2.2
Book value / share
₹18.33
ROE
12.02%
ROCE
13.74%
ROA
10.98%
Debt / equity
0x
Dividend yield
0%
52-week range
₹40.75 – ₹76

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Fortis Malar Hospitals Ltd (FORTISMLR) reported net profit of ₹4.14 crore and earnings per share of ₹2.21. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, net profit ₹-0.05 crore (consolidated).

Consolidated annual results for Fortis Malar Hospitals Ltd (FORTISMLR), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)86.1885.9559.0100
Net profit (₹ cr)-8.27-15.4845.320.394.14
EPS (₹)-4.41-8.2624.180.212.21
Compound annual growth for Fortis Malar Hospitals Ltd (FORTISMLR). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Profit growth4.53%--961.54%
Stock price CAGR-1%-5%-6%-30%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 62.71% of Fortis Malar Hospitals Ltd (FORTISMLR) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.07%. Market capitalisation was ₹97 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY M 4.86%, RUCKMANI NATARAJAN 2.07%, SUNITA KANTILAL VARDHAN 1.27%, A M GOPALAN 1.23%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202662.71%--0.07%37.29%
Mar 202662.71%--0.07%37.29%
Dec 202562.71%--0.07%37.29%
Sep 202562.71%--0.07%37.29%
Jun 202562.71%--0.07%37.29%
Mar 202562.71%--0.07%37.29%
Dec 202462.71%--0.07%37.29%
Sep 202462.71%--0.07%37.29%
Every quarter since Mar 2001 Filing data, not investment advice.